Orchasp Limited has provided additional clarification regarding the timing of its INDUSAYUSH electronic health records platform admission on Google Play Store, following an inquiry from the stock exchange's Listing Compliance Monitoring team. The company issued a detailed response on January 5, 2026, explaining the timeline of events surrounding the app's launch.

Platform Launch Timeline Clarification

The company clarified that the INDUSAYUSH app was admitted to Google Play Store on December 31, 2025, at 8:22 AM PST (USA time), which corresponded to 9:52 PM IST on the same day. The platform launch represents a significant milestone in Orchasp's digital healthcare initiatives.

Compliance Response and Announcement Timeline

The company addressed concerns about the timing of its regulatory announcement, explaining that the office was closed on January 1, 2026, due to New Year holidays. Orchasp noticed the platform's acceptance on Google Play Store on January 2, 2026, and made the announcement immediately thereafter.

Regulatory Compliance Details

The clarification was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company emphasized that there was no intentional delay in the announcement, stating that the disclosure was made immediately upon discovery during regular business hours.

The communication was addressed to both major stock exchanges:

• BSE Limited (Scrip Code: 532271)
• The National Stock Exchange of India Ltd (Symbol: ORCHASP)

The disclosure was signed by P. Chandra Sekhar, Managing Director & CFO (DIN: 01647212), maintaining proper corporate governance standards.

Digital Healthcare Platform Status

The INDUSAYUSH electronic health records platform is now fully operational on Google Play Store, marking Orchasp's entry into the mobile healthcare application space. The platform aims to streamline patient data management and enhance accessibility for healthcare providers, aligning with the growing trend of digital health solutions.

Orchasp Limited has taken the next crucial step in its preferential allotment process, with the board of directors formally approving the implementation of the ₹8.60 crore share issuance. Following the in-principle approvals received from both major stock exchanges in December, the company's board meeting held on December 18 has now authorized the actual allotment and necessary regulatory applications.

Board Meeting Outcomes and Approvals

The board meeting, which commenced at 11:00 AM and concluded at 1:00 PM on December 18, resulted in key decisions regarding the preferential allotment implementation:

The board has specifically approved the issuance to Mrs. P. Rajeswari, who is the legal heir of Mr. P.C. Pantulu, the former chairman and CEO of the company. This allotment will facilitate the conversion of his outstanding loan amounts into equity.

Regulatory Framework and Exchange Approvals

The preferential allotment has already secured in-principle approval from both BSE Limited and NSE of India Limited under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. However, the exchanges have emphasized that this approval should not be construed as automatic listing approval for the securities.

Management Authorization and Next Steps

The board has authorized Mr. P. Chandra Sekhar, Managing Director and CFO, to handle all necessary applications and compliance requirements. His responsibilities include making applications with BSE, NSE, ROC, CDSL, and NSDL, along with obtaining required permissions under applicable laws for issue, allotment, listing, and trading permissions.

The company must ensure strict compliance with internal controls to monitor trades executed by proposed allottees before the allotment of securities. Additionally, specific undertakings must be obtained from allottees confirming they will not engage in intra-day trading in the company's scrip until the allotment date.

Post-Allotment Compliance Timeline

Upon completion of the allotment, Orchasp will be required to make a listing application without delay, along with applicable fees, as per Regulation 14 of the LODR Regulations. The company must submit this application within twenty days from the date of allotment, as specified in Schedule XIX Para(2) of ICDR Regulations and SEBI circular dated June 21. Non-compliance with these timeline requirements will attract penalties as mentioned in the relevant SEBI circular.